A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells

Binita Das, Beth K. Neilsen, Kurt W. Fisher, Drew Gehring, Youcai Hu, Deanna J. Volle, Hyun Seok Kim, Jamie L. McCall, David L. Kelly, John B. MacMillan, Michael A. White, Robert E. Lewis

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

AMPK is a serine threonine kinase composed of a heterotrimer of a catalytic, kinase-containing α and regulatory β and γ subunits. Here we show that individual AMPK subunit expression and requirement for survival varies across colon cancer cell lines. While AMPKα1 expression is relatively consistent across colon cancer cell lines, AMPKα1 depletion does not induce cell death. Conversely, AMPKα2 is expressed at variable levels in colon cancer cells. In high expressing SW480 and moderate expressing HCT116 colon cancer cells, siRNA-mediated depletion induces cell death. These data suggest that AMPK kinase inhibition may be a useful component of future therapeutic strategies. We used Functional Signature Ontology (FUSION) to screen a natural product library to identify compounds that were inhibitors of AMPK to test its potential for detecting small molecules with preferential toxicity toward human colon tumor cells. FUSION identified 5′-hydroxy-staurosporine, which competitively inhibits AMPK. Human colon cancer cell lines are notably more sensitive to 5′-hydroxy-staurosporine than are non-transformed human colon epithelial cells. This study serves as proof-of-concept for unbiased FUSION-based detection of small molecule inhibitors of therapeutic targets and highlights its potential to identify novel compounds for cancer therapy development.

Original languageEnglish (US)
Article number3770
JournalScientific Reports
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

AMP-Activated Protein Kinases
Colonic Neoplasms
Colon
Neoplasms
Cell Line
Cell Death
Protein-Serine-Threonine Kinases
Biological Products
Small Interfering RNA
Phosphotransferases
Therapeutics
Epithelial Cells
Survival

ASJC Scopus subject areas

  • General

Cite this

A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. / Das, Binita; Neilsen, Beth K.; Fisher, Kurt W.; Gehring, Drew; Hu, Youcai; Volle, Deanna J.; Kim, Hyun Seok; McCall, Jamie L.; Kelly, David L.; MacMillan, John B.; White, Michael A.; Lewis, Robert E.

In: Scientific Reports, Vol. 8, No. 1, 3770, 01.12.2018.

Research output: Contribution to journalArticle

Das, Binita ; Neilsen, Beth K. ; Fisher, Kurt W. ; Gehring, Drew ; Hu, Youcai ; Volle, Deanna J. ; Kim, Hyun Seok ; McCall, Jamie L. ; Kelly, David L. ; MacMillan, John B. ; White, Michael A. ; Lewis, Robert E. / A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. In: Scientific Reports. 2018 ; Vol. 8, No. 1.
@article{1c7039cc31ed4670922c606bd1c3ff8d,
title = "A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells",
abstract = "AMPK is a serine threonine kinase composed of a heterotrimer of a catalytic, kinase-containing α and regulatory β and γ subunits. Here we show that individual AMPK subunit expression and requirement for survival varies across colon cancer cell lines. While AMPKα1 expression is relatively consistent across colon cancer cell lines, AMPKα1 depletion does not induce cell death. Conversely, AMPKα2 is expressed at variable levels in colon cancer cells. In high expressing SW480 and moderate expressing HCT116 colon cancer cells, siRNA-mediated depletion induces cell death. These data suggest that AMPK kinase inhibition may be a useful component of future therapeutic strategies. We used Functional Signature Ontology (FUSION) to screen a natural product library to identify compounds that were inhibitors of AMPK to test its potential for detecting small molecules with preferential toxicity toward human colon tumor cells. FUSION identified 5′-hydroxy-staurosporine, which competitively inhibits AMPK. Human colon cancer cell lines are notably more sensitive to 5′-hydroxy-staurosporine than are non-transformed human colon epithelial cells. This study serves as proof-of-concept for unbiased FUSION-based detection of small molecule inhibitors of therapeutic targets and highlights its potential to identify novel compounds for cancer therapy development.",
author = "Binita Das and Neilsen, {Beth K.} and Fisher, {Kurt W.} and Drew Gehring and Youcai Hu and Volle, {Deanna J.} and Kim, {Hyun Seok} and McCall, {Jamie L.} and Kelly, {David L.} and MacMillan, {John B.} and White, {Michael A.} and Lewis, {Robert E.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-22090-6",
language = "English (US)",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells

AU - Das, Binita

AU - Neilsen, Beth K.

AU - Fisher, Kurt W.

AU - Gehring, Drew

AU - Hu, Youcai

AU - Volle, Deanna J.

AU - Kim, Hyun Seok

AU - McCall, Jamie L.

AU - Kelly, David L.

AU - MacMillan, John B.

AU - White, Michael A.

AU - Lewis, Robert E.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - AMPK is a serine threonine kinase composed of a heterotrimer of a catalytic, kinase-containing α and regulatory β and γ subunits. Here we show that individual AMPK subunit expression and requirement for survival varies across colon cancer cell lines. While AMPKα1 expression is relatively consistent across colon cancer cell lines, AMPKα1 depletion does not induce cell death. Conversely, AMPKα2 is expressed at variable levels in colon cancer cells. In high expressing SW480 and moderate expressing HCT116 colon cancer cells, siRNA-mediated depletion induces cell death. These data suggest that AMPK kinase inhibition may be a useful component of future therapeutic strategies. We used Functional Signature Ontology (FUSION) to screen a natural product library to identify compounds that were inhibitors of AMPK to test its potential for detecting small molecules with preferential toxicity toward human colon tumor cells. FUSION identified 5′-hydroxy-staurosporine, which competitively inhibits AMPK. Human colon cancer cell lines are notably more sensitive to 5′-hydroxy-staurosporine than are non-transformed human colon epithelial cells. This study serves as proof-of-concept for unbiased FUSION-based detection of small molecule inhibitors of therapeutic targets and highlights its potential to identify novel compounds for cancer therapy development.

AB - AMPK is a serine threonine kinase composed of a heterotrimer of a catalytic, kinase-containing α and regulatory β and γ subunits. Here we show that individual AMPK subunit expression and requirement for survival varies across colon cancer cell lines. While AMPKα1 expression is relatively consistent across colon cancer cell lines, AMPKα1 depletion does not induce cell death. Conversely, AMPKα2 is expressed at variable levels in colon cancer cells. In high expressing SW480 and moderate expressing HCT116 colon cancer cells, siRNA-mediated depletion induces cell death. These data suggest that AMPK kinase inhibition may be a useful component of future therapeutic strategies. We used Functional Signature Ontology (FUSION) to screen a natural product library to identify compounds that were inhibitors of AMPK to test its potential for detecting small molecules with preferential toxicity toward human colon tumor cells. FUSION identified 5′-hydroxy-staurosporine, which competitively inhibits AMPK. Human colon cancer cell lines are notably more sensitive to 5′-hydroxy-staurosporine than are non-transformed human colon epithelial cells. This study serves as proof-of-concept for unbiased FUSION-based detection of small molecule inhibitors of therapeutic targets and highlights its potential to identify novel compounds for cancer therapy development.

UR - http://www.scopus.com/inward/record.url?scp=85043234220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043234220&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-22090-6

DO - 10.1038/s41598-018-22090-6

M3 - Article

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 3770

ER -